I too woke up early (2.30am here in nz) the call was good and I came away positive. for me once again the key direction from the Ilera merger is to gain early benefit realisation from the clinical data assets Zelda has though the USA and ex US. aka revenue generating.
the company needs to think further ahead that just near term trial results. but what to do with them ilera make that path clear.
I was very happy on the talk of IP and USA markets
Ann: Zelda to merge with US-based Ilera Therapeutics, page-83
-
- There are more pages in this discussion • 232 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
